论文部分内容阅读
Protein kinase CK2 is a multifunctional serine/threonine kinase that is involved in a broad range of physiological events.The tricyclic quinoline compound CX-4945 is the first orally bioavailable CK2 inhibitor.CX-4945 analogs compound 13 with R3 carboxylate function were demonstrated to be 4050-fold less potent than compound 6m (R2=COOH) in vitro.Molecular docking (GOLD 4.0) and molecular dynamics simulations (AMBER 10) were employed to elucidate the structural mechanisms through which the R3 carboxylic acid substituent influence binding affinity.